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INTRODUCTION 
Fistula in ano is a common surgical problem encountered in the out patient clinic.  
It is a condition which can be often diagnosed clinically with meticulous examination.   It 
is mostly due to a benign cause which can be treated with surgical therapy therapy.  
The treatment, although mainly surgical,   involves consideration of certain systemic 
causes and prompt diagnosis and treatment of the same.  Tuberculosis is one such  
ubiquitous cause , especially in  developing countries.  Various studies have found 
tuberculosis to be the cause to varying extents in cases of fistula in ano.  However, the 
exact magnitude of the disease burden is not known. 
Another problem with tuberculosis, in any form, is the difficulty in making a 
prompt diagnosis in order to start anti-tuberculous therapy.  Even though a battery of 
tests exist, only some tests have stood the test of time and have been considered as 
gold standard. These tests are microscopy and culture demonstrating presence of M. 
tuberculosis in the specimen in question.  However, even these tests have their 
shortcomings, a fact which has led to the quest for faster and more accurate tests.  One 
such test is Polymerase Chain Reaction (PCR), a test which allows the amplification of 
a specific strand of DNA in a sample by enzymatic reaction, such that trace amounts 
this DNA (which represents the Nucleic acid of the species to be detected) are picked 
up and amplified, thus confirming the diagnosis. 
Fistulae caused by M.tuberculosis are difficult to diagnose because of low 
concentration of the acid fast bacilli in the tissue.  Another factor is the overlap in the 
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histopathological appearance between tuberculosis and other infections causing 
granulomatous inflammation. 
The present study tries to answer two of the questions regarding tuberculous 
fistula in ano.  It tries to determine the prevalence of tuberculosis as a cause of fistula in 
ano.  It also tries to look at how useful PCR is in diagnosing tuberculous fistula in ano. 
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STATEMENT OF STUDY QUESTION 
WHAT IS THE PREVALANCE OF TUBERCULOUS FISTULA IN ANO IN A TERTIARY 
CARE CENTRE? 
HOW USEFUL IS PCR AS A DIAGNOSTIC TOOL FOR TUBERCULOUS FISTULA IN 
ANO 
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AIMS & OBJECTIVES 
Aims 
1. To evaluate the prevalence of tuberculous fistula in ano in patients attending 
a tertiary care centre. 
2. To determine the sensitivity and the specificity of PCR in the diagnosis of 
Tuberculous fistula in ano. 
Objectives 
To establish the disease burden of tuberculous fistula in ano among patients 
seen in the out patient department of a tertiary care centre (Christian Medical College) 
in Vellore. 
To establish the role of PCR  as a  reliable method to diagnose tuberculous 
fistula in ano.  The study aims at evaluating PCR as a tool for quick and reliable 
diagnosis of Tuberculous fistula in ano where the histopathology of the tract is 
indeterminate, thus saving the patient a 6-8 week wait before initiation of Anti -
Tuberculous Therapy. 
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LITERATURE REVIEW 
FISTULA IN ANO – AN OVERVIEW 
One of the not so uncommon problems with which a patient presents  to the 
general or colorectal surgeon in the  out patient clinic is a protracted history of perianal 
discharge, often with associated history of having had multiple procedures for the same 
at another centre.  Although the diagnosis of a fistula in ano for the above problem 
comes easily to a surgeon after a proper digital rectal examination, the treatment can be 
difficult.  The entity of the fistula in ano has been afflicting man for long.       
Hippocrates, in about 430 B.C., suggested that the disease was caused by “contusions 
and tubercles occasioned by rowing or riding on horseback”.  The fascination with anal 
fistula for more than 2,000 years is manifested by the numerous papers and books on 
the subject. (1) 
SYMPTOMS 
The presentation of fistula in ano is typical in most cases. 
The most frequent presenting complaints of patients with an anal fistula are 
swelling, pain, and perianal discharge.  The two former symptoms usually are 
associated with an abscess when the external or secondary opening has closed or has 
failed to develop. Most patients with an overt fistula have an antecedent history of 
abscess that drained spontaneously or for which surgical drainage had been performed.  
The discharge, however is mostly seropurulent, rarely blood tinged.  The patients seeks 
medical help only if he has pain and swelling (? Abscess) or if the discharge becomes a 
  9
nuisance.  The time period before the onset of the discharge and the presentation to the 
clinic varies with individuals’ awareness about personal hygiene.  This is the natural 
history of about 50% of the perianal abscess.(2) 
PATHOLOGY 
The pathology in fistula in ano is a fistulous tract between the anal canal (or the 
rectum) and the perianal skin which is lined with granulation tissue.  The granulation 
tissue lining the tract may be representative of the pathology or may be non specific.  
The presence and the position of the openings of the tract (internal and external) can be 
one or more than one and the course of the tract between the two can be varied.  This 
factor is used to classify the tracts and also helps in deciding on treatment. 
CLASSIFICATION 
A clear understanding of the anatomy of the anal canal and the related structures 
is essential to understand  the pathogenesis and classification of fistula in ano We shall 
therefore briefly discuss the same before coming to the classification of anal fistulae. 
ANATOMY OF THE ANAL CANAL AND THE MUSCLES OF CONTINENCE (3) 
Anal canal 
The muscular anal canal forms a sphincter at the distal end of the gastrointestinal 
(G.I.) tract.  The adult anal canal is about 4 cm long. Posteriorly the anal canal is 
separated from the tip of the coccyx by fibro fatty and muscle tissue known as the ano 
coccygeal ligament. The ischiorectal fossae  lie on either side of the anal canal and are 
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continuous with each other via the retrosphinteric space situated between the coccygeal 
attachment of the external anal sphincter below and the levator ani above. Anteriorly, 
the perineal body or the central tendon of the perineum seperates the anal canal from 
the vagina or from the membranous urethra and bulb. 
At the level of the dentate line, which is present in the zona columnaris,  and  
represents the embryonic anal membrane site,  marking the change in lining of the anal 
canal from columnar epithelium above it to the anal epithelium below it,  are transverse 
folds of mucosa form a ring of anal valves.   Immediately above these are shallow 
pockets (the anal sinuses or anal crypts).  In the connective tissue zone between the 
sphincter ani muscles and the epithelial lining of the anal canal (zona columnaris) in this 
region, eccrine secreting glands, or “anal glands”, open into the crypts through ducts 
which have a glandular lining. (4) The anal glands, 5-10 in number, either branch in the 
submucosal plane, or, more frequently, penetrate the internal sphincter to end by 
branching in the intersphinteric plane between the internal and external anal sphincters.  
In some cases they extend only as far as the submucosa, while in others the gland 
enters the internal sphincter muscle and dilates in an ampulla like structure. 
Significance of the dentate line 
The dentate line marks the level of opening of than anal glands at the anal valves 
and thus is often the starting point of the abscess which lead to the formation of anal 
fistulae.  The internal opening of the fistula, therefore often lies at the level of the 
dentate line. 
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The anal sphincters 
The sphincter mechanism of the anal canal consists of the internal and external 
anal sphincters. The internal anal sphincter is a downward extension of the circular 
layer of the rectal muscle wall and is thus a smooth muscle tube under control of the 
autonomous nervous system.  The external anal sphincter surrounds the internal and is 
continuous with the fibres of the levator ani muscle.  It forms a skeletal muscle 
extension from the pelvic floor. 
The upper part of the external sphincter, at the level of the anorectal junction, is 
the puborectalis muscle which forms a sling around the anorectal junction being 
attached anteriorly to the posterior aspect of the pubis. In the resting state, the ano 
rectal tube is angled forward at this level and contraction of the puborectalis sling will 
increase this angle, an important factor in the continence mechanism. The anorectal 
ring is palpable on rectal examination. 
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While the internal sphincter is a well developed downward extension of the 
circular muscle layer of the rectum, the longitudinal layer contributes a far less discrete 
component.  Partly muscle and partly fibrous tissue, it runs down to end as fibrous 
bands passing through the perianal fat and lower part of the external sphincter, to be 
attached to the skin. The fat of the perianal space is this broken up into small loculi. 
The levatores ani form the pelvic diaphragm supporting the pelvic viscera.  The 
structures passing through the pelvic diaphragm lie within the sling of puborectalis.  The 
levatores arise in continuity from the pelvic bone in front and from a thickening of the 
obturator fascia and the spine of the ischium laterally.  They are inserted into the coccyx 
and the anococcygeal ligament posteriorly.  The coccygeus muscle forms the posterior 
part of pelvic floor, its under surface being continuous with the sacrococcygeal ligament 
as seen from the perineal aspect.  The nerve supply of the levator ani is from the 3rd 
and 4th sacral segments. 
The interspinteric space 
The interval between the internal and external sphincters is known as the 
intersphincteric space.  The anal intramuscular glands, which open into the anal crypts, 
pass through this space before penetrating into the internal sphincter. 
No essential nerves or blood vessels cross the space and the plane of dissection 
is fairly easily developed between the internal and external anal sphincters in an 
intersphinteric excision of the rectum. 
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Having thus discussed the relevant anatomy of the anal canal and the sphincteric 
muscles, it would be easier to understand the basis for classification of the fistula in 
ano. 
The categorization of a fistula-in-ano is dependent on its location relative to the 
anal sphincter muscles according to Parks classification.  (5,6): 
 Submucous 
 Intersphincteric 
 Transsphincteric 
 Suprasphincteric 
 Extrasphincteric 
The term submucous fistula is a misnomer because the condition does not fulfill 
the criterion for the definition of a fistula: a tract between two epithelial surfaces.  These 
can be considered as intersphinteric fistulae. 
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The fistula forms between the internal and external sphincter. 
The common type tracks down to present at the lower end of the internal 
sphincteric muscle as a perianal abscess. 
Sometimes it tracks upwards and forms a second opening in the anus or rectum 
above that of the anal intramuscular glands. The track thus formed is not submucous 
(as was formerly thought) but intersphincteric. 
The tract may extend into the pelvirectal space superiorly, and similarly a pelvic 
abscess may extend down the intersphinteric plane and present as a perianal abscess. 
 
The infection extends from the intersphincteric plane at the mid anal canal level 
through the external sphincter into the ischiorectal fossa where it forms an abscess 
which then ruptures on to the perianal skin. 
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A secondary tract may extend upward through the levator ani and produce a 
pelvic abscess.  The induration on rectal examination is felt at the anorectal ring. 
 
A pelvic extension of an intersphincteric abscess discharges through levator ani 
into the ischiorectal fossa. The tract curves above the puborectalis sling. 
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The Extra sphincteric tract lies outside both the internal and the external 
sphincter muscles. 
It may be caused by a trans sphincteric fistula which has entered the rectum  at a 
higher level.  It can be a sequelae to direct taruma to the perineum, Crohn’s disease, or 
a carcinoma of the rectum. 
A reasonable estimate of the distribution of the various types of fistulae in ano 
would be Intersphinteric 70%, Transsphinteric 23%, Suprasphincteric 5%,and 
Extrasphinteric 2%. 
The term “complex” fistula is often used to describe “difficult to treat fistulae”.(2)  
They are fistulae which pose a higher risk of sphincter injury and hence incontinence.  
They have been more objectively defined as a modification of the Parks classification. 
An anal fistula may be termed “complex” when:- 
1. The track crosses >30 to 50 percent of the external sphincter (high-
transsphincteric, suprasphincteric, and extrasphincteric), 
2. is anterior in a female, 
3. has multiple tracks, 
4. is recurrent, 
5. or the patient has preexisting incontinence, local irradiation, or Crohn’s 
disease. 
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TREATMENT  OF FISTULA IN ANO 
The goals in fistula in ano treatment are the follwing: 
1. To recognise and eliminate any septic foci in the perianal region and any 
associated epithelialised tracts. 
2. To do so with minimal impairement of normal function. 
Various techniques exist to treat fistulae.  The merits and demerits of these have 
been discussed as follows. 
Fistulectomy and Fistulotomy 
A fistulotomy, includes defining the entire fistula track from internal opening to 
external opening with identification and obliteration of primary and secondary tracks. A 
fistulectomy on the other hand, involves coring out the tract in its entirety from the 
internal to the external opening. Fistulotomy is preferable to fistulectomy in spite of 
similar recurrence rates as the latter results in larger wounds with a longer healing time 
and higher rates of incontinence. The recurrence rate for fistulotomy is generally 
between 2 and 9 percent with a functional impairment generally between 0 and 17 
percent.(7) Patients with high openings, posterior openings, or fistula extensions are at 
risk to develop continence disorders after anal fistulotomy.(7) 
Another procedure which is of use in decreasing wound healing time significantly 
is marsupialisation of the wound, a procedure which involves suturing of the wound 
edges with the fistula tract with interrupted absorbable sutures. This was found to 
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decrease the time of wound healing by up to 4 weeks with no significant increase in 
infection rates (8,9) 
Seton 
Fistula in ano can also be treated with the use of a seton and/or staged 
fistulotomy A seton is a flexible foreign body (e.g., suture material, silastic vessel loop or 
a loop of linen) that is placed through the fistula track and secured to itself. Hippocrates 
was the first person to advocate the use of a seton (from the Latin seta, a bristle) in 
treatment by taking a very slender thread of raw lint, uniting it into five folds of the length 
of a span, and wrapping them round with a horse hair.(1) 
The use of setons is based on the assumption that they cause a chronic 
inflammatory reaction and consequent fibrosis that fixes and prevents retraction of the 
sphincter when it is divided. Based on whether the seton is tightened around the 
tissues, the setons can be classified as “cutting seton”  and the “loose seton” which is 
used to perform a  two-stage fistulotomy (TSSF).(10,11,12) The cutting seton, by 
periodic tightening around the tissues encircled, gradually transects the muscle by 
pressure necrosis. In the TSSF, the seton is left loose around the tissue encircled by the 
fistula to stimulate fibrosis and facilitate drainage of sepsis. Division of the muscle 
encircled by the fistula is then performed as a second procedure. Proponents of the 
cutting seton argue that they do not need a second operation, whereas those in favour 
of the TSSF argue that the cutting seton produces unnecessary pain and divides the 
sphincter in an uncontrolled way. 
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Recurrence rates have been found to be nearly equal after use of cutting setons 
and TSSF (0-8%).  Minor incontinence was also found to be present in about 50% of 
patients after TSSF and Cutting seton insertion. Major incontinence was present in 
about 5% of patients with the use of TSSF and of about 10% patients after use of 
cutting setons. It is therefore evident that the TSSF is just as effective in treatment of 
fistula as compared to the more painful cutting seton. (11,12,13)  The rates of 
recurrence in cases of Crohn’s disease have been found to be higher  (upto 39%) (14). 
Mucosal flap advancement 
Another modality of treatment of fistula in ano includes what is called the 
mucosal flap advancement. The fistulous tract, running from the external opening to the 
external anal sphincter is excised as well. The tract running through the sphincters is 
curetted. The defect in the internal anal sphincter is then closed with absorbable 
sutures. The next step involves covering the internal opening with a mucosal or a skin 
based flap. There are two ways of raising flaps, the first being from the mucosa proximal 
to the internal opening which is advanced distally, taking care to include the muscularis 
propria with it.  The incision begins distal to the internal opening, and the flap is 
mobilized, excising the scar. Some suggest an oblique incision, but this risks ischemic 
necrosis at the apex. Others prefer mobilization in a circumferential fashion, 
incorporating as much as 50% of the rectum. The dissection can be facilitated by means 
of infiltration with a dilute epinephrine solution. (15) 
The concept of endoanal or endorectal mucosal advancement has evolved into 
three principal methods: vertical tongue flaps, semilunar lip flaps, and circumferential 
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tubal or sleeve flaps.  The second method involves an (inverted) U shaped flap 
including perianal skin and fat, is created, taking care not to undermine the flap to 
prevent ischemia. The flap is designed in such a way that the base of the flap is 
approximately twice the width of its apex. The flap is advanced into the anal canal and 
sutured to the mucosa and underlying internal anal sphincter in a single layer, proximal 
to the closed internal opening, using interrupted, absorbable sutures. The perianal 
wound is left open.(15) . 
The mucosal advancement flap has a cure rate of upto 80-90 percent in most 
studies(16,17,18) . Schouten showed in his studies that use of anal advancement flaps 
had a reduced continence to flatus in 38% and faeces 12%. (19) 
Fibrin glue 
Another way of treating fistula in ano is to inject into the tracts (after curretting the 
granulation tissue) fibrin glue which intiates healing , with minimal surgical trauma.  This 
procedure gives an over all healing rate of 69% for all fistula in ano.(20,21) Another 
study found that the fibrin glue was 33% succesful and 14% succesful in closing primary 
and recurrent fistula respectively(22). 
When compared with fistulotomy, the fibrin glue was found to be more effective in 
treating complex as compared to simple fistulae, healing 69% of the complex and only 
50% of the simple fistulae as compared to 13% and 100% healing rates in the 
corresponding fistulotomy arms. (23) 
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Fibrin glue treatment is simple and repeatable; failure does not compromise 
further treatment options; and sphincter function is preserved.(23) 
It has also been demonstrated that combining the fibrin glue with an 
advancement flap shows worst outcome as compared to the fibrin glue or the 
advancement flap alone.(24) 
Fistula plug 
The fistula plug is a bioprosthetic material which is inserted into the tract to 
promote occlusion of the tract and healing.  Although initial results were promising, on 
long term follow up the fistula plug has shown poor healing rates of only 13-24% with 
high incidence of post operative local sepsis. (25,26,28) 
To summarize, for the treatment of fistula in ano, one should keep in the mind 
that, Marsupialization after fistulotomy reduces bleeding and allows for faster healing. 
Results from small trials suggest flap repair may be no worse than fistulotomy in terms 
of healing rates but this requires confirmation. Flap repair combined with fibrin glue 
treatment of fistulae may increase failure rates. (20) 
In keeping with the goals mentioned above the principles of operative management are 
as follows:- 
Identify the tract.(using a probe) 
Incise the tract (using electrocautery) or debride and obliterate with fibrin glue, or 
place a seton, or close the internal opening with a mucosal advancement flap. 
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Excise a portion for biopsy material (if considered potentially useful). 
Pack with Vaseline Gauze after hemostasis is secured 
Following this the patient is advised to have regular sitz baths with use of laxatives and 
local anaesthetics. 
It must be understood that no single technique can be used to treat every fistula.  
The key point is the surgeon’s discretion in deciding how much of the sphincter if 
divided will be a reasonable trade off between post operative healing rates and 
functional detriment. During division of the sphincter, if needed, the surgeon needs to 
keep in mind the presence of   Crohn’s disease or previous radiation therapy. Other 
factors which are important in deciding on post operative functional status are  
1. preexisting incontinence 
2. previous mechanical sphincter injury, 
3. an anterior location in females,  
4. stool consistency, and finally  
5. the patient’s tolerance of potential imperfections in their continence. 
Complications of fistula surgery are many and include fecal soilage, mucous 
discharge, varying degrees of incontinence (gas and/or stool), and recurrent abscess 
and fistula. 
 
  23
ETIOLOGY OF FISTULA IN ANO 
The etiology of fistula in ano can be classified into the following heads 
Cryptoglandular fistula in ano  - 90% 
Specific causes (10%)   - Crohns Disease, Tuberculosis, Malignancy 
Others (<1%)  - Sarcoidosis, Syphilis, Venereal lymphogranuloma          
and Actinomycosis 
It would be safe to say that about 90% of the fistula in ano can be classified as 
cryptoglandular in origin.  About 4-10 mucin producing anal glands are present at the 
level of the dentate line, draining into the anal crypts.(2)   Fecal  plugging of the ducts 
leads to obstruction and subsequent abscess formation.  The abscess may spread 
through and in between the sphincters and track along the muscular, fascial and fatty 
planes around the anus at any anatomical level vertically, horizontally or 
circumferentially. This process represents the cryptoglandular theory of anal sepsis. 
Robinson and Seow have suggested that the description of the anal glands by Chiari in 
1878 and the subsequent histological studies of Parks in 1961 contributed to the 
acceptance of the cryptoglandular theory as the most common cause for anal 
sepsis.(28,30) 
Even though the majority of the cases of fistula in ano are caused by a benign 
cause, there is a small but definite proportion of anal fistulae which owe their origin to a 
more sinister cause and require accurate diagnosis, differentiation and management to 
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achieve healing.  In a study with 233 patients who underwent operations for ano rectal 
sepsis, 11.6% were found to harbor systemic disease.(31) 
These not so uncommon causes of fistula in ano which need to be considered 
and treated on a systemic basis include Crohn's disease and tuberculosis and 
malignancy.  The other rare causes of fistula in ano are such as sarcoidosis, syphilis, 
venereal lymphogranuloma and actinomycosis should also be considered. 
On of the not uncommon causes in India is Tuberculosis.  Anorectal tuberculosis, 
although considered to be rare, is a cause of considerable importance because of the 
fact that the fistulae caused by M. tuberculosis are 1) Difficult to diagnose and 2) will not 
heal unless the diagnosis is made promptly and treatment with anti tuberculous drugs 
prescribed for an adequate duration. 
Before we consider the various aspects of tuberculosis as a cause of fistula in 
ano, a brief description of gastrointestinal tuberculosis will help us in understanding the 
burden and the etiopathophysiology of the disease. 
GASTROINTESTINAL TUBERCULOSIS 
Tuberculosis (TB) can involve any part of the gastrointestinal tract from mouth to 
anus, the peritoneum and the pancreatobiliary system. It frequently mimics other 
common and rare diseases posing difficulties in its diagnosis and prompt treatment. TB 
of the gastrointestinal tract is the 6th most frequent form of extra-pulmonary in India. (32) 
The other forms of  extrapulmonary tuberculosis (EPTB)  tuberculosis, which  are 
more common than gastrointestinal TB, in decreasing order of their prevelance are   
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lymphatic ,  genitourinary , bone and joint , miliary  and  meningeal tuberculosis.   The 
manifestation of extrapulmonary manifestations of tuberculosis have increased from 
16% to 21% between 1993 and 2005 in the USA, according to the Centers for Disease 
Control and Prevention.(33) 
Gastrointestinal tuberculosis accounts for about 10-15 percent of the cases of 
tuberculosis.  Although there have been reports of intestinal involvement in upto 55-90 
percent of cases with pulmonary tuberculosis in the pre anti tuberculosis therapy era,  a 
study ( based on autopsies )  done between 1964 to 1970 showed presence of 
abdominal tuberculosis in 3.72% of  cases with pulmonary tuberculosis.(32) 
Among the various forms of gastrointestinal tuberculosis, those affecting the 
anus  often manifest as anal fistulae. 
TUBERCULOSIS IN FISTULA IN ANO 
Tuberculous involvement of the anus is rare(29). According to some authors, 
anorectal tuberculosis is mostly associated with active pulmonary tuberculosis. The 
postulated mechanisms by which tubercle bacilli reach the perianal region are: 1) 
Hematogenous spread from the primary lung focus in childhood with later reactivation; 
2) ingestion of bacilli in sputum from active pulmonary focus; 3) direct spread from the 
adjacent organs; and 4) through lymph channels from infected nodes. 
Tuberculous origin must be considered when the cause of perianal ulcers is 
unclear. 
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The percentage of cases of fistula in ano caused by tuberculosis varies, with 
figures varying from 0.7 % to 21 % of the cases of fistula in ano. (34,35,36,37,38,39) 
Anorectal tuberculosis has been classified by Nepomuceno et al  into 4 
categories: ulcerative, verrucous, lupoid, and miliary. The most common type is 
ulcerative tuberculosis, which usually is a result of a primary source often found in the 
lung or intestines. The verrucous type is characterized by a warty appearance. The 
lupoid type starts as a reddish-brown nodule and eventually forms an ulcer in its center, 
whereas miliary lesions are associated with a systemic process. Fistulae may develop 
from any of these initial types.(40). Other atypical presentations are recurrent perianal 
growth, anal fissure, anal strictures, and a rectal submucosal tumor.(35) 
Most frequently encountered anorectal tuberculous lesions are suppurations and 
fistulae. Other presenting features may be anal pain, fever and cough, anal or perianal 
ulcer with purulent exudates and a nonhealing wound around the anus. (35,37) 
Nearly all tuberculous fistulae are complex, and secondary tracks or additional 
complicating features are commonly found even at first presentation. (41) 
Tuberculosis can be present in HIV-positive patients.(42) The incidence and 
severity of ano-perianal tuberculosis are increasing with increasing incidences of HIV 
infection.  Few other clinical conditions mimicking tuberculosis are hidradinitis 
suppurativa, bartholinitis, radiation injuries, lymphomas and antibiomas. 
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INVESTIGATIONS FOR TUBERCULOSIS IN FISTULA IN ANO 
The key factor in the diagnosis and therefore treatment of tuberculosis, more so 
in its extra pulmonary and smear negative forms, is that of time.  Although early 
diagnosis of infection is important before the use of antituberculous chemotherapy 
clinical diagnosis is usually dependent on microscopic detection using Ziehl-Neelsen 
stain and mycobacterial culture, but the sensitivity and specificity of these two methods 
are low.  Various tests have been introduced so as to try and diagnose a case of 
tuberculosis as early as possible, with a reliable degree of specificity and sensitivity so 
as to start ATT promptly. 
Some of the tests have been discussed as follows:- 
The diagnostic tests available for the detection of tuberculosis in the present day 
are microscopy, culture, drug susceptibility tests, rapid tests like NATS or Phage 
Assays, or immune based tests like tuberculin, Interferon Gamma release assays. 
MICROSCOPY 
Slides are stained with carbolfuchsin (e.g. Ziehl-Neelsen (ZN) stain) or 
fluorochrome dyes (auramine stain) and examined with light and fluorescent 
microscopy.  The advantages of microscopy for detection of M. tuberculosis are many.  
The smears are cheap, rapid and detects the most infectious cases.  In areas of high 
TB prevalence microscopy is considered relatively specific for Mycobacterium 
tuberculosis (90 - 95%).  In Ziehl-Neelsen staining, the smear is covered with carbol 
fuchsin dye for a few minutes. After heating, rinsing with water and the acid-alcohol 
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treatment, the smear is counterstained with another dye, methylene blue (to colour the 
background of the smear for contrast) and then rinsed again (WHO 2004). Once dried, if 
there was a substantial concentration of TB bacilli in the specimen, some of the bacilli 
on the slide should show up under the microscope as red , characteristically rod-shaped 
organisms, against the blue.  The lab technician must meticulously examine each slide 
and then record the number of organisms observed (grading the burden — which can 
predict severity of disease in HIV-negative people). From sample collection until 
microscopic examination, the process takes at least a couple of hours. The microscopic 
examination itself is a labour intensive and time consuming procedure. However, even 
though the technique is simple enough to be performed even in settings with 
rudimentary facilities, it is not very sensitive. There has to be a very high concentration 
of bacilli in the specimen in order for the lab technician to detect the ten or more 
organisms needed for a clear, positive result. Even a skilled eye working in a well-
maintained laboratory is unlikely to detect TB when there are fewer than 5000–10,000 
bacilli per ml of sputum. Such a high of a burden of bacilli is typically only found in 
adults with advanced pulmonary disease — and rarely in earlier disease, or when the 
disease is active in other parts of the body (extrapulmonary TB), in people with HIV or in 
children. Therefore, for paucibacillary tuberculosis,  AFB smear microscopy is limited by 
its poor sensitivity (45%--80% with culture-confirmed pulmonary TB cases) and its poor 
positive predictive value (50%--80%) for TB in settings in which nontuberculous 
mycobacteria are commonly isolated (43,44) . 
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MYCOBACTERIAL CULTURE 
Apart from the demonstration of AFB positive bacilli by direct microscopic 
examination of the specimen, a positive culture proving the presence of AFB (M. 
tuberculosis) remains the gold standard for the diagnosis of TB, particularly in 
immunocompromised smear-negative patients.  The sensitivity of AFB smear and 
culture, though,  are low; cultures grow mycobacteria in 39 to 80% of cases. (39) The 
advantage that AFB culture has over microscopy is that it is much more sensitive than 
the microscopy, being able to detect as few as 10 bacteria/ml of material (46,47). There 
is also the need for precise speciation which culture addresses, also providing live 
organisms for drug susceptibility testing and genotyping of the organisms.  Therefore, it 
is advisable to inoculate (after appropriate digestion and decontamination, if required) 
all clinical samples. In general, the sensitivity of culture is 80-85% with a specificity of 
approximately 98% (43,44). 
The diagnosis of tuberculosis disease is mainly bacteriologic in adults. 
Three different types of traditional culture media are available: 
1. 1.Egg based (Lowenstein-Jensen),  
2. 2.Agar based (Middlebrook 7HlO or 7Hll medium), and    
3. Liquid (Middlebrook 7H12 and other commercially available broths). 
Each can be made into selective media by adding antibiotics.  Of the solid media, 
growth of mycobacteria tends to be slightly better on the egg-based medium but more 
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rapid on the agar medium. Growth in liquid media is faster than growth on solid media.  
However, liquid media can be used for primary isolation of mycobacteria from nonsterile 
sites only if supplemented with an antibiotic cocktail. 
A major improvement in mycobacteriology has been the development of 
commercial broth systems for mycobacterial growth detection.  Automated culture 
systems in this line are the  Liquid-based commercial culture systems BACTEC460 
(Becton Dickinson Microbiology Systems, Sparks, MD), mycobacterial growth indicator 
tube (MGIT) systems, ESP (Extra Sensing Power) Myco-ESPculture System II (Trek 
Diagnostic Systems, Inc., Westlake, OH), and BacT/ALERT MB Susceptibility Kit 
(Organon Teknika, Durham, NC). These use Middlebrook 7H12 media with added 
material for detection of mycobacteria (radiometric or calorimetric systems).  The chief 
advantages of these are the more rapid turnaround time (10 - 14 days for growth, 
compared with ≥3 weeks on solid media) and improved sensitivity.  However, the 
contamination rates are higher with some of the liquid-based systems. At least one 
container of solid medium should be inoculated and used in conjunction with broth 
culture systems. Egg-based media such as Lowenstein-Jensen slants are an important 
backup for rare M. tuberculosis strains that may not grow on the other media. 
Automated liquid systems should be checked at least every 2-3 d for growth while solid 
media should be checked once or twice a week. Mycobacterial growth observed on 
solid culture media should be quantified. Growth in liquid culture systems cannot be 
similarly quantitated although a qualitative measure of organisms in the inoculum can 
be made by noting the time required for liquid culture to turn positive. 
. 
  31
Phage-based assays 
These assays use mycobacteriophages to infect any viable M. tuberculosis 
present in a sample. 
The remaining extracellular phages are killed by the addition of a viricidal agent, 
and the protected intracellular phages are subsequently detected as clear areas or 
plaques in a lawn of rapidly growing indicator mycobacteria. An alternative, more rapid 
detection system uses genetically engineered bacteriophages with a luciferase reporter 
gene that allows detection through the emission of light. The assay can be modified for 
the rapid testing of resistance to Rifampicin . Although these tests show good sensitivity 
and specificity when used on culture isolates, the performance of these tests is 
diminished when used on field samples directly.  This limits the use of these tests. 
Tuberculin skin test 
The tuberculin skin test (TST), involving the intra-dermal inoculation of a known 
amount of tuberculin protein, followed by the recording and interpretation of the 
subsequent induration, measures some aspects of the host’s cell-mediated immune 
response to TB. The interpretation of the test is complicated by cross-reactions in 
persons either vaccinated with BCG or exposed to environmental mycobacteria, and 
false-negative results can occur owing to anergy. Most importantly, the TST does not 
differentiate latent infection from TB disease although it is still often used as an 
adjunctive diagnostic test in the paediatric setting. 
 
  32
The present day algorithm which is followed for a patient who presents to the out patient 
clinic in our institution to rule out, diagnose and if required, treat tuberculous fistula in 
ano is as follows: (EUA and LOF – Examination under Anaesthesia and Lay open of 
Fistula) 
Case of fistula in ano 
 
 
 
EUA and LOF with Curettage of the fistulous track lining 
 
 
 
          Hematoxylin and Eosin staining                           AFB smear and Culture 
 
 
 
  wait for culture(6-8 weeks) 
+ve for TB            -ve for TB           
                                                                             +ve for TB 
 
 
                                                                                                  -ve for TB
 
 
Anti  tuberculous therapy                                                                 
               
       
Follow up till resolution of symptoms 
 
However, there is an inherent problem with the above algorithm, one of 
diagnosing tuberculosis with certainty in cases where 1) The AFB smear from the tissue 
is negative and 2) when the histopathological examination is not conclusively diagnostic 
of tuberculosis.  In these cases, the clinician needs to wait for a period of about 6-8 
weeks for the M.tuberculosis culture to rule out or rule in tuberculosis before starting 
treatment. 
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The main difficulty with extrapulmonary specimens is that they yield very few 
bacilli and consequently are associated with low sensitivity of acid-fast bacillus (AFB) 
smear and culture. Acid-fast staining was positive in fewer than 10% of patients in most 
reports, whereas pleural fluid cultures for M. tuberculosis were positive in up to 12 to 
70% of cases and pleural biopsies revealed granulomas in 50 to 97% of patients with 
tuberculous pleural effusion. (45) 
Of all the forms of gastrointestinal tuberculosis, tuberculous fistula in ano is 
probably one  of the most paucibacillary types. Also, various other diseases, particularly 
Crohn’s disease show granulomas on histology, with the culture or smear not showing 
any evidence of tuberculosis, confounding the picture.  In view of the fact that 
Tuberculous fistula in ano is paucibacillary and the attendant difficulties in detection, a 
test that increases the number or yield of bacteria is required.  The Nuclear 
Amplification Tests (NATS), in this regard have emerged as test with 1) greater positive 
predictive value (>95%) with AFB smear-positive specimens in settings in which 
nontuberculous mycobacteria are common and 2) ability to confirm rapidly (24-48 
hours) the presence of M. tuberculosis in 50%-80% of AFB smear-negative, culture-
positive specimens (48,49,50,51,52). Compared with culture, NATs can detect the 
presence of M. tuberculosis bacteria in a specimen weeks earlier than culture for 80%-
90% of patients suspected to have pulmonary TB whose TB is ultimately confirmed by 
culture (48,49,50).  The Polymerase Chain Reaction (PCR) is one such NAT. 
The basic PCR principle is simple. As the name implies, it is a chain reaction: 
One DNA molecule is used to produce two copies, then four, then eight and so forth. 
This continuous doubling is accomplished by specific proteins known as polymerases, 
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enzymes that are able to string together individual DNA building blocks to form long 
molecular strands. To do their job polymerases require a supply of DNA building blocks, 
i.e. the nucleotides consisting of the four bases Adenine (A), Thymine (T), Cytosine (C) 
and Guanine (G). They also need a small fragment of DNA, known as the primer, to 
which they attach the building blocks as well as a longer DNA molecule to serve as a 
template for constructing the new strand. If these three ingredients are supplied, the 
enzymes will construct exact copies of the templates. This process is important, for 
example, when DNA polymerases double the genetic material during cell division. 
Besides For the copying procedure only a small fragment of the DNA section of interest 
needs to be identified. This then serves as a template for producing the primers that 
initiate the reaction. It is then possible to clone DNA whose sequence is unknown. This 
is one of the method’s major advantages. The enzyme which is used to accomplish the 
DNA polymerization at such high temperatures is from the bacillus Thermus aquaticus, 
and its heat-stable polymerase, called Taq polymerase. 
It uses repeated cycles, each of which consists of three steps: 1. The reaction 
solution containing DNA molecules (to be copied), polymerases (which copy the DNA), 
primers (which serve as starting DNA) and nucleotides (which are attached to the 
primers) is heated to 95°C. This causes the two complementary strands to separate, a 
process known as denaturing or melting. 2. Lowering the temperature to 55°C causes 
the primers to bind to the DNA, a process known as hybridization or annealing. The 
resulting bonds are stable only if the primer and DNA segment are complementary, i.e. 
if the base pairs of the primer and DNA segment match. The polymerases then begin to 
attach additional complementary nucleotides at these sites, thus strengthening the 
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bonding between the primers and the DNA. 3. Extension: The temperature is again 
increased, this time to 72°C. This is the ideal working temperature for the polymerases 
used, which add further nucleotides to the developing DNA strand. At the same time, 
any loose bonds that have formed between the primers and DNA segments that are not 
fully complementary are broken. Each time these three steps are repeated the number 
of copied DNA molecules doubles.  After 20 cycles about a million molecules are cloned 
from a single segment of double stranded DNA. The temperatures and duration of the 
individual steps described above refer to the most commonly used protocol.(52,53,54) 
 
Certain PCRs are designed to amplify nucleic acid regions specific to the 
Mycobacterium tuberculosis complex.  These tests can be used directly on clinical 
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specimens (eg. Sputum).  PCRs are also available as commercial kits which include 
reagents to extract and then amplify nucleic acid chains when subject to a certain set of 
conditions.   The in-house base Polymerase chain reaction (PCR) assays vary widely in 
their protocols and methods. 
The literature on NAT demonstrates high specificity for pulmonary and 
extrapulmonary TB. However, data on extra pulmonary forms of TB are limited.   The 
high specificity of NATs helps to rule in TB in cases with high pretest probability.  (55) 
In contrast to the specificity, the sensitivity (The ability of the test to rule out the 
disease) is lower and highly variable. The sensitivity is especially low in paucibacillary 
forms of tuberculosis (namely extra pulmonary forms of TB).  The sensitivity of NATs 
has been the highest in smear positive specimen.  Therefore, the negative test does not 
rule out the disease.   There have been reports of use of the IS6110 as an amplification 
target and the use of nested PCR with higher accuracy. (56,57) 
Various samples have been used to try and diagnose with a greater accuracy , or 
to evaluate the role of  PCR  as a tool for the diagnosis of Extra Pulmonary 
Tuberculosis. 
Certain reports state the sensitivity and negative predictive value of peripheral 
blood samples from 38 EPTB and 89 non tuberculous subjects as 60.53% and  76.92% 
respectively, which is superior to the present gold standard of mycobacterial culture 
(10.53 and 72.36%). However, 43.82% of non tuberculous subjects gave positive 
results with the PCR, thus mitigating the clinical utility of this test.(58) 
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Other studies have used stool samples as specimens to diagnose intestinal 
tuberculosis and have found a sensitivity, specificity, positive predictive value and a 
negative predictive value of 88.8%, 100%, 100%, and 93.7% respectively. (59) 
Urine has been used as a specimen in some studies, with similar results.(60,61) 
The use of tissue from the site of suspected lesion as a specimen for the PCR 
has been tried.   The IS6110 is a 123 base pair (bp) restriction fragment length 
polymorphism (RFLP) fragment which is specific for Mycobacterium tuberculosis as it is 
repeated multiple number of times in the species DNA.   There have been various 
studies which have used this base pair sequence as a specific marker for the detection 
of the Mycobaterium tuberculosis genome in the specimen with varying degrees of 
success.    Studies involving direct detection of  Mycobacterium bovis in  bovine lymph 
node samples (with macroscopic features of tuberculosis) using PCR have shown 
concordance in the positive rates with the PCR and the Cultures.  (62) 
Another study used 191 non-repeated clinical samples of EPTB and 17 samples 
from non-tuberculous cases as controls. All the samples were stained for acid fast bacilli 
(AFB) and 143 samples were processed by culture for M. tuberculosis.  All the samples 
were processed for PCR amplification with primers targeting 123 bp fragment of 
insertion element IS6110 of M. tuberculosis complex. Of the 191 samples processed, 34 
(18%) were positive by smear for AFB. Culture for AFB was positive in 31(22%) of 143 
samples processed. Either smear or culture for AFB was found positive in 51(27%) 
samples. Of the 191 samples processed 120 (63%) were positive by PCR. In 140 
samples, wherein both the conventional techniques were found negative, 74 (53%) 
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samples were positive by PCR alone. Among 51 samples positive by conventional 
techniques, 46 (90%) were found positive by PCR.  (63,64) 
Another study which used sputum  PCR and compared it with conventional 
diagnostic methods (smear and culture)  found a sensitivity, specificity, positive 
predictive value and a negative predictive value of 85%, 97%, 94%, and 94% 
respectively for the IS6110 123 base pair insertion sequence. 
Therefore, the use of PCR with the IS6110 123 bp insertion sequence as the 
target sequence to diagnose the presence of M. tuberculosis in a given sample does 
show promise.  However, its role in aiding the diagnosis of tuberculous fistula in ano 
remains largely unknown.  This study aims at throwing light on the same. 
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MATERIALS AND METHODS 
 Study design – The study was a prospective blinded crossectional study with the 
evaluation of a diagnostic tool. 
 Patients, clinical information, and clinical specimens. 
 Patients with fistula in ano were drawn from those attending the Out patient 
department of General surgery Units II and V of the Christian Medical College, Vellore 
over a period of 20 months (from September 2007 to April 2009).   A detailed clinical 
history, physical examination, baseline laboratory investigations to asses fitness for 
surgery were conducted for all patients. 
 At the time of the operation, a sample of the curetted fistulous tract was obtained 
and was cryo preserved at -196 degree C for later use.   Bits from the same fistulous 
tract curettage were sent for AFB smear and culture examination and hematoxylin and 
eosin histopathological examination (HPE). 
 The HPE reports were followed up subsequently. 
 The AFB culture were followed up for a period of 10 weeks for growth of 
Mycobacterium tuberculosis. 
 The cryopreserved specimens were subjected to PCR for the presence of IS6110 
amplification target. 
 The clinical diagnosis was not known to the laboratory personnel conducting the 
PCR tests. 
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Sample size 
 The sample size was calculated by using the prevalence as established by a 
previous retrospective study done in the Department of General Surgery Unit V which 
had determined the prevalence of tuberculous fistula in ano as 6.6%. (ref. unpublished 
data) 
 The formula used for calculation of the sample size was 4pq/d2, where P is the 
expected prevalence, Q is (1-P), and D is the degree of accuracy expected out of the 
study.  It was decided to do the study with an expected degree of accuracy of +/- 3%, as 
this would need a sample size which could be completed in the study period.  
Therefore, using this formula, a sample size of 263 was calculated. 
STATISTICAL ANALYSIS OF DATA 
 The patients whose samples are used in the study were analyzed by way of their 
distribution of age, sex, number of fistulae found on clinical examination and total 
number of procedures done for the same complaints. 
 The prevalence of tuberculosis was thus calculated based on the number of 
patients positive for the gold standard tests divided by the total number of patients 
examined over the study period. 
 The number of samples which were positive for AFB smear and/or are positive 
for tuberculosis on histopathological examination were grouped together as positive for 
the gold standard test. 
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 The number of patients who were positive for Mycobacterium tuberculosis 
genome on PCR examination were considered to be test positive for the diagnostic tool 
being evaluated. 
 A two by two table as follows was thus constructed with the above data. 
Total number of cases examined = X 
Total number of cases positive for histopathology or AFB culture = Y 
Total number of negative cases = Z 
AFB C/S    AND/OR HPE     + VE               - VE 
 
+ VE PCR 
 
- VE  
 
 
 Y      +       Z    =    X 
The PREVALENCE of tuberculous fistula in ano 
No. of HPE and or AFB culture +ve cases (Y) 
   Sample size attained in the study period (X) 
 
A 
(TP) 
B 
(FP) 
C 
(FN) 
D 
(TN) 
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The SENSITIVITY of PCR 
               The positive cases in PCR (Test +ve) (A) 
    The cases +ve for HPE and or AFB culture (disease +ve) (A+C) 
The SPECIFICITY of PCR is 
The number of cases negative for PCR (Test –ve)(D) 
 Number of cases -ve for HPE and or AFB culture(Disease -ve)(B+D) 
 
The POSITIVE PREDICTIVE VALUE is 
    The number of cases with the actual disease (A)  
       The number of cases with Positive PCR (A+B) 
 
The NEGATIVE PREDICTIVE VALUE is 
The  number of cases with no disease (D)  
                  The number of cases with negative PCR(C+D) 
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RESULTS 
TOTAL CASES 
A total of 231 samples were included in the study. These samples were derived 
from 228 patients. 
AGE 
The mean age of the patients was 42 years, with a range of 12-69 years of age. 
SEX 
217, 95%
11, 5%
Male Female
 
 
The majority of the patients were males and only 11 (4.8%) were females. 
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OTHER VIRAL INFECTIONS 
None of the patients were HIV positive. However, 3 patients were HbsAg positive and 
one patient was HCV positive. 
TUBERCULOSIS 
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7 patients were diagnosed to have tuberculous fistula in ano based on either 
histopathology or AFB culture. Therefore, a prevelance of 3.07% was determined. 
DURATION OF SYMPTOMS 
The mean duration of symptoms before the patients presented was 31 months 
with a range of half a month to 20 years. 
NUMBER OF TRACTS 
58 patients had greater than one tract at the time of presentation. 
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NUMBER OF PROCEDURES 
50 patients had undergone three or more perianal procedures at the time of 
presentation at various centers including ours. However, only 12 of these patients had 
more than one tract. 
PREVELANCE OF TUBERCULOSIS 
Tuberculosis was diagnosed in 7 out of the 228 patients. This gave a prevelance 
of 3.07 % for tuberculosis among patients of fistula in ano. All these patients were males 
with an average age of 44 years of age. 
NUMBER OF TRACTS IN TUBERCULOSIS PATIENTS 
Most of the patients (n= 6) diagnosed to have tuberculosis had single tracts. 
DURATION OF SYMPTOMS AMONG THE TUBERCULOUS FISTULA IN ANO 
PATIENTS 
The average duration of symptoms among the tuberculous fistula in ano patients 
was 18 months, with a range of 4 months to 3 years. 
BIOPSY AND CULTURE POSITIVE 
3 patients were biopsy positive. 3 patients were culture positive. One patient was 
biopsy and culture positive. 
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PCR POSTIVES 
PCR Results
77
99
Positive Negative
 
A total of 176 samples were subjected to PCR, of which 77 samples were found 
to be PCR positive for tuberculosis.  Six of these samples were positive for tuberculosis 
by culture or histopathology.  
OTHER BIOPSY 
The other biopsy reports encountered were adenocarcinoma (1 patient), Crohn's 
disease (1 patient) , and granular cell tumour (1 patient). 
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THE TWO BY TWO TABLE WAS THUS FORMED :- 
AFB CULTURE AND/OR HISTOPATHOLOGY POSITIVE 
   +                           - 
PCR 
+ 
 
- 
 
 
SENSITIVITY = 4/6 = 66% 
SPECIFICITY = 97/ 170 = 57% 
PPV = 4/77 = 5.19% 
NPV = 2/99 = 2.02% 
4 
TP 
73 
FP 
2 
FN 
97 
TN 
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DISCUSSION 
Sex 
According to literature, fistula in ano is a male predominant disease. In this study 
as well, it emerges as a disease primarily affecting males. Only 4.8% out of 228 patients 
were females. 
Age 
Although there is no defined age group which has been described as being 
affected by fistula in ano, in this study it is evident that the disease mostly affects middle 
aged males. The males in this study were of the range from 12- 69 years with a mean 
age of 42 years. 
Duration of symptoms 
Fistula in ano seems to be a chronic disease in our patients, the average 
duration of symptoms before a patient presented to the institute being 31 months. 
However, 50 of the total patients had undergone multiple procedures elsewhere. The 
maximum duration of symptoms recorded was 20 years. 
Relation between Number of tracts and number of procedures 
Only a small proportion of the patients (25%) of the patients presented with more 
than one tract.  However, the number of tracts did not seem to have a bearing on the 
number of procedures undergone by the patients as most of the patients who had 
multiple procedures (three or more) before presentation had single tracts. 
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Prevalence of tuberculosis 
The prevalence of tuberculosis among patients of fistula in ano was found to be 
3.07%.  This was well within the earlier estimated range of 0.7 % to 21 % of the cases 
of fistula in ano. (34,35,36,37,38,39).  This prevalence does show that tuberculosis is a 
definite cause of fistula in ano among our populations, and needs to be ruled out with 
appropriate tests. 
However, considering the fact that this institute is a referral center, a higher 
prevalence might be expected. If this is true, then whether this is a case of under 
diagnosis is debatable. 
The diagnosis of tuberculosis is difficult. The difficulty is even more for the 
diagnosis of extra pulmonary tuberculosis due to the paucibacillary form of the disease. 
As a result, the two tests, namely Histopathology and AFB culture, which have been 
used as the gold standard tests in this study also have their limitations. 
Histopathological diagnosis of tuberculosis is usually observed in the presence of 
granulomatous inflammation and caseous necrosis. In the absence of caseous 
necrosis, the final diagnosis depends only on the granulomatous inflammation. 
However, it is not specific for tuberculosis as it can be present in a variety of other 
conditions such as sarcoidosis, syphilis, leprosy, Crohn’s disease, rheumatoid arthritis, 
systemic lupus erythematosus, and pneumoconiosis (66). 
Histopathology has been found to have a limited sensitivity varying from 46-75%  
(67,68,69)  However, these values represent figures from studies conducted on patients 
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clinically diagnosed to have tuberculosis.  The pretest probability and therefore the 
validity attributable to these results, therefore, increases.  Only 4 out of 231 samples 
(from 228 patients, none of whom were clinically diagnosed to have tuberculous fistula 
in ano) were found to be biopsy positive in our study. 
Tuberculous PCR has been evaluated in confirming the diagnosis where the 
biopsy shows granulomas with no demonstrable AFB and in formalin-fixed, paraffin-
embedded histologic specimens. These studies have found sensitivity rates from 56-
67% with a specificity of about 64% in one such study (70,71,72).  However, these 
studies have used samples which have shown granulomas on biopsies, thus raising the 
pretest probability of tuberculosis to be likely diagnosis. A positive TB PCR on these 
specimens can therefore be considered diagnostic of tuberculosis.  Another fact that 
emerged from these studies was that TBPCR was more likely to be positive in cases 
where the histopathological features were more in favour of tuberculosis. Considering 
HPE as gold standard, a study evaluating TBPCR has shown 74.1% sensitivity and 
96.1% specificity (66).  This study could be compared to ours since the samples were 
not from any specific subset of patients in whom a diagnosis of tuberculosis (clinical or 
histopathological) was already made.  Of the three patients who were found to be 
biopsy positive in our study, only one was found to be TBPCR positive, which 
incidentally was also found to be culture positive.  The sensitivity of TBPCR for biopsy is 
therefore only 33% in our study. 
The culture for M. tuberculosis also has similar problems.  It is known to be highly 
specific (upto 98-100%) but has variable sensitivity from 39% to about 85%. 
(44,45,46,47). Studies which have compared culture to TBPCR have found sensitivity 
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85-90% and a specificity of about 98-100% from specimens which were from patients 
already diagnosed to have tuberculosis. (48,49,50,42,43,44,57,58) In our study, it was 
found that TBPCR has a sensitivity of 100% and a specificity of only 41% when 
compared to M. tuberculosis culture. 
It has also been shown that the correlation between histopathological and 
microbiological results can be poor and also be affected by the quality of specimens 
collected for both. In a retrospective study over 4 years, it was found that tuberculosis 
was concomitantly diagnosed in only 67% by culture and biopsy whereas, 97% were 
diagnosed as TB or 'compatible with TB' by histology alone. For 7% of these the final 
diagnosis was found to be other than TB.(73) In our study, only one of the seven (14%) 
positive samples was positive for culture and biopsy both. Two samples were diagnosed 
positive on the basis of biopsy alone and four samples were diagnosed to be positive on 
the basis of culture alone. 
As stated above, 77 patients were PCR positive for the presence of 
Mycobacterium tuberculosis DNA presented in the samples with only 4 true positives 
among these. Even though this reflects a high false positive rate, what is striking is that, 
among the samples which were actually picked up by the PCR, all are culture positive. 
The rest of the two samples which were not picked up by the PCR were samples which 
were diagnosed on the basis of histopathology and were finally found to be AFB culture 
negative. 
This makes us consider the fact that the PCR is accurate in amplifying the M.  
tuberculosis DNA in all the samples when present and showing a positive result. The 
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question which arises then is, why there were so many (n=73) false positives?  This can 
probably be explained by considering the possible presence of M. tuberculosis as a 
contaminant in the samples, as a part of the resident stool flora in a significant portion of 
our population. This hypothesis can however be only proven by performing PCR for M. 
tuberculosis on the stool samples of these patients.  However, what goes against this 
hypothesis is a study which used stool from normal patients or patients treated for 
tuberculosis as controls for TBPCR  and found all  specimens (n=30) to be negative for 
the same (i.e. a specificity of 100%).(59) Our study shows a specificity of 57%. 
Another factor which can be considered to explain the high false positive rate 
could be due to carry-over contamination during collection, storage, or processing. (66) 
In the present study, different steps of PCR (DNA extraction, pre-PCR mixing, PCR, and 
post-PCR gel documentation) were conducted in different rooms, reducing the chances 
of contamination. 
It must also be kept in mind that even though culture and biopsy are not tests 
with a wide and rather poor range of sensitivity, they have been considered the gold 
standard tests for the lack of any other test. It shall therefore not be unwise to keep in 
mind the possibility that had the gold standard tests been more sensitive, the number of 
cases diagnosed to have definite tuberculous fistula in ano would have been higher and 
therefore the number of false positives would have been lower. 
Another possible explanation to account for the false positive results would be 
that in these cases the disease was still developing and well-developed granuloma or 
numbers had not yet formed, or bacillary load was not enough for culture to show 
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positive results but enough to be  detected by PCR. Whether this is true can be 
ascertained by two ways ; 1) By following up these patients in time to determine how 
many of them develop recurrence or resistance to conventional methods of treatment or 
2) By empirically treating them with ATT and observe them for healing of these 
fistulae.(66) To start treatment on the basis of positive TBPCR may not be completely 
acceptable given the low pretest probability of these patients to have tuberculosis. 
Out of the 228 patients who were included in this study,  one patient was found to 
have an adenocarcinoma. This is consistent with some studies which show that chronic 
fistula in an can be associated with mucinous adenocarcinoma.(74,75) 
Only one case among 228 patients was diagnosed to have Crohn’s disease on a  
histological basis. 
Another fact which was evident in the above study was the fact that none of the 
patients who were diagnosed to have tuberculosis were diagnosed to have concomitant 
pulmonary tuberculosis.  This is in contradiction to the earlier belief  some studies which 
have suggesting a definitive association between the two.(76) 
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CONCLUSIONS 
1. Tuberculosis is an rare but definite cause of fistula in ano. It should be 
actively ruled out by testing specimens by histopathological as well as 
microbiological (Culture) means. 
2. Fistula in ano is a chronic disease affecting mostly males. 
3. Tuberculous fistula in ano can exist as and entity independent from 
pulmonary or other systemic involvement of the disease. 
4. TBPCR does not appear to be an useful test in diagnosing tuberculous fistula 
in ano due to a high rate of false positive results.  However, in culture positive 
samples, TBPCR is 100% sensitive in detecting the same. 
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LIMITATIONS OF THE STUDY 
1. Delay in processing the samples after collection may have altered the results. 
2. The possibility of carry over contamination could not be ruled out, thus casting 
a doubt on the interpretation of the results in light of the high false positive 
rates. 
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